The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Regional · North America · continued

Follow-up: State-level differences that actually matter posts 91–97

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

B
BBramleyTL3Regular8 Apr 2026#91
j.fonseca, post #75: Building on post #74 rather than restating it. Emotional language in an appeal does not help, however justified it is. The reviewer is checking criteria and the job is to make them checkable. Go to post

Thank you for taking the time. That was more work than a reply usually is.

13 likes in reply to #75 4mo
TT
t.tullochTL28 Apr 2026#92

Answering the question post #89 raises rather than the one it answers.

State-level differences: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.

27 likes 4mo
L
LeitermanTL3Regular9 Apr 2026#93

Where a manufacturer runs a direct supply route, that is a commercial arrangement rather than a regulatory change, and it can end.

If this contradicts something upthread, the upthread version may well be the better one.

0 likes 4mo
GE
g.ekstromTL29 Apr 2026#94

Say which country and which state or province. Regulatory position, availability and practical route can all differ within the same continent and frequently do.

The literature is thinner on this than the confidence in the thread implies.

2 likes 4mo
JV
j.vandermolenTL3Regular9 Apr 2026#95
mira.patel, post #88: Prior authorisation criteria are usually published by the payer and reading them before the appointment changes the outcome more than anything else does. I would want a second opinion before relying on that. Go to post

Adding the measurement that post #92 says would settle it.

The claim about State-level differences upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".

8 likes in reply to #88 4mo
NS
n.serranoTL29 Apr 2026 · edited#96
resistance_first, post #15: Reframing State-level differences slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how often", nobody here knows. Go to post

My understanding of State-level differences is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.

19 likes in reply to #15 4mo
GV
g.valckenaereTL3Regular9 Apr 2026#97

The public assessment documents published at approval are free, detailed and largely unread here.

It took me longer than it should have to see that.

0 likes 4mo
Promoted into the documentation commons. The content of this topic is maintained at Access notes: Canada, with named maintainers and a review date. The promotion was discussed in doc review. Corrections are best raised against the document, which is the version that gets kept current.

Suggested topics

TopicParticipantsRepliesViewsActivity
State-level differences that actually matter
On the subject in the title: State-level differences that actually matter Working notes rather than a conclusion. The question about state-level differences that I actually want answered is the second one…
TPJVSRGVGE+6 10 56k 10mo
Revisiting: US compounding rules and how they changed
On the subject in the title: Revisiting: US compounding rules and how they changed Working notes rather than a conclusion. Regional question, dated February 2026, because everything in this category expires.…
LECKDHKI+5 9 26k 23mo
About the North America category
US and Canadian regulation, compounding, and coverage. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a note. If the scope…
KTVEKCNB+3 7 43k 9mo
[2026 update] US compounding rules and how they changed
US compounding rules and how they changed Writing it up because I had to work it out twice and would rather nobody else did. Regional question, dated January 2026, because everything in this category expires.…
FWTTAHECKH+32 37 7.4k 10mo
Canadian access and provincial variation
Posting this under the heading it deserves: Canadian access and provincial variation Everything below is what sits behind that. Trying to establish the boundary conditions on canadian access and provincial…
POCLNNTPFV+74 80 7.7k 18mo

Related topics — sharing the tags FDA, telehealth, insurance

TopicParticipantsRepliesViewsActivity
An appeal that succeeded, with the letter structure — the long version
An appeal that succeeded, with the letter structure — the long version — setting out what I have, and where I think it stops being reliable. A narrow question about appeal, deliberately narrow, because the…
GTAKJNBPMS+113 136 32k 1mo
Discussing something you have already been doing
On the subject in the title: Discussing something you have already been doing Working notes rather than a conclusion. A question about how to describe something to a clinician rather than about the thing…
ECRFOOIAKF+10 14 3.4k 10mo
[2026 update] Travelling with an injectable: documentation and practicalities
Travelling with an injectable: documentation and practicalities Writing it up because I had to work it out twice and would rather nobody else did. Dated regional question, February 2026, because everything in…
VSDAWIBB+107 111 12k 1d
What a regulator's shortage notice actually authorises
What a regulator's shortage notice actually authorises — that is the question, and I have not found it answered plainly anywhere I have looked. Asking what a regulator's document actually says, since the…
BESCAAQLSG+8 12 15k 17h
Discussing something you have already been doing — the long version
Discussing something you have already been doing — the long version Writing it up because I had to work it out twice and would rather nobody else did. A question about how to describe something to a clinician…
ITATALENG+14 18 58k 12mo